Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study.
Yokohata E, Kuwatsuka Y, Ohashi H, Terakura S, Kawashima N, Seto A, Kurahashi S, Ozawa Y, Goto T, Imahashi N, Nishida T, Miyao K, Sakemura R, Kato T, Sawa M, Kohno A, Sao H, Iida H, Kiyoi H, Naoe T, Miyamura K, Murata M. Yokohata E, et al. Among authors: iida h. Bone Marrow Transplant. 2017 Apr;52(4):612-614. doi: 10.1038/bmt.2016.323. Epub 2017 Jan 9. Bone Marrow Transplant. 2017. PMID: 28067879 Clinical Trial. No abstract available.
Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies.
Miyao K, Sawa M, Kuwatsuka Y, Ozawa Y, Kato T, Kohno A, Sao H, Nishida T, Iida H, Naito K, Tsurumi H, Taji H, Mizuta S, Kusumoto S, Nakase K, Morishita Y, Kawashima N, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Miyao K, et al. Among authors: iida h. Bone Marrow Transplant. 2016 Jan;51(1):157-60. doi: 10.1038/bmt.2015.235. Epub 2015 Oct 5. Bone Marrow Transplant. 2016. PMID: 26437064 No abstract available.
Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.
Inamoto Y, Nishida T, Suzuki R, Miyamura K, Sao H, Iida H, Naoe T, Maruyama F, Hirabayashi N, Hamaguchi M, Iseki T, Kami M, Yano K, Takeyama H, Morishita Y, Morishima Y, Kodera Y. Inamoto Y, et al. Among authors: iida h. Bone Marrow Transplant. 2007 Jan;39(1):25-30. doi: 10.1038/sj.bmt.1705543. Epub 2006 Nov 20. Bone Marrow Transplant. 2007. PMID: 17115063
Short-term methotrexate could reduce early immune reactions and improve outcomes in umbilical cord blood transplantation for adults.
Narimatsu H, Terakura S, Matsuo K, Oba T, Uchida T, Iida H, Hamaguchi M, Watanabe M, Kohno A, Murata M, Sawa M, Miyamura K, Morishita Y. Narimatsu H, et al. Among authors: iida h. Bone Marrow Transplant. 2007 Jan;39(1):31-9. doi: 10.1038/sj.bmt.1705539. Epub 2006 Nov 20. Bone Marrow Transplant. 2007. PMID: 17115066 Clinical Trial.
Clinical characteristics of chronic graft-versus-host disease following umbilical cord blood transplantation for adults.
Sugimoto K, Narimatsu H, Kawase T, Iida H, Watanabe M, Kohno A, Kuwatsuka Y, Uchida T, Hamaguchi M, Terakura S, Naoe T, Matsuo K, Murata M, Sawa M, Miyamura K, Morishita Y; Nagoya Blood and Marrow Transplantation Group (NBMTG). Sugimoto K, et al. Among authors: iida h. Bone Marrow Transplant. 2008 Apr;41(8):729-36. doi: 10.1038/sj.bmt.1705959. Epub 2008 Jan 7. Bone Marrow Transplant. 2008. PMID: 18176617
Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy.
Inamoto Y, Ito M, Suzuki R, Nishida T, Iida H, Kohno A, Sawa M, Murata M, Nishiwaki S, Oba T, Yanada M, Naoe T, Ichihashi R, Fujino M, Yamaguchi T, Morishita Y, Hirabayashi N, Kodera Y, Miyamura K; Nagoya Blood and Marrow Transplantation Group. Inamoto Y, et al. Among authors: iida h. Bone Marrow Transplant. 2009 Jul;44(1):43-9. doi: 10.1038/bmt.2008.419. Epub 2009 Jan 12. Bone Marrow Transplant. 2009. PMID: 19139727
Cytomegalovirus antigenemia and outcome of patients treated with pre-emptive ganciclovir: retrospective analysis of 241 consecutive patients undergoing allogeneic hematopoietic stem cell transplantation.
Yanada M, Yamamoto K, Emi N, Naoe T, Suzuki R, Taji H, Iida H, Shimokawa T, Kohno A, Mizuta S, Maruyama F, Wakita A, Kitaori K, Yano K, Hamaguchi M, Hamajima N, Morishima Y, Kodera Y, Sao H, Morishita Y. Yanada M, et al. Among authors: iida h. Bone Marrow Transplant. 2003 Oct;32(8):801-7. doi: 10.1038/sj.bmt.1704232. Bone Marrow Transplant. 2003. PMID: 14520425
Donor single nucleotide polymorphism in the CCR9 gene affects the incidence of skin GVHD.
Inamoto Y, Murata M, Katsumi A, Kuwatsuka Y, Tsujimura A, Ishikawa Y, Sugimoto K, Onizuka M, Terakura S, Nishida T, Kanie T, Taji H, Iida H, Suzuki R, Abe A, Kiyoi H, Matsushita T, Miyamura K, Kodera Y, Naoe T. Inamoto Y, et al. Among authors: iida h. Bone Marrow Transplant. 2010 Feb;45(2):363-9. doi: 10.1038/bmt.2009.131. Epub 2009 Jun 15. Bone Marrow Transplant. 2010. PMID: 19525985
Disease stage stratified effects of cell dose in unrelated BMT for hematological malignancies: a report from Japan Marrow Donor Program.
Inamoto Y, Miyamura K, Okamoto S, Akiyama H, Iida H, Eto T, Morishima Y, Kawa K, Kikuchi A, Nagatoshi Y, Tanaka J, Ashida T, Hirokawa M, Tsuchida M, Mori S. Inamoto Y, et al. Among authors: iida h. Bone Marrow Transplant. 2011 Sep;46(9):1192-202. doi: 10.1038/bmt.2010.281. Epub 2010 Nov 8. Bone Marrow Transplant. 2011. PMID: 21057551
2,114 results